HDPRO Co., Ltd. announced that it expects to receive KRW 15 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
December 18, 2018
Share
HDPRO Co., Ltd. (KOSDAQ:A214870) announced a private placement of 4th series unregistered coupon unguaranteed private convertible bonds for gross proceeds of KRW 15,000,000,000 on December 19, 2018. The transaction will include participation from DB Financial Investment Co.,Ltd., Investment Arm. The bonds carry coupon rate of 2% and have yield to maturity of 3%. The bonds will mature on February 19, 2022. The bonds are fully convertible into 3,514,526 common shares of the company at a fixed conversion price of KRW 4,268 per conversion share from February 19, 2020 to January 19, 2022. The transaction is expected to close on February 19, 2019. The transaction has been approved by the board of directors of the company.
NewGLab Pharma Co Ltd, formerly NewGLab Co Ltd, is a company mainly engaged in the manufacturing and sale of closed-circuit television (CCTV) cameras. The Company's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The Company distributes its products within domestic market and to overseas markets.
NEWGLAB PHARMA CO.,LTD 
